Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Attenuation of obesity-induced insulin resistance in mice with heterozygous deletion of ROCK2.

International journal of obesity (2005)·2016

Same author

Target-specific regulation of presynaptic release properties at auditory nerve terminals in the avian cochlear nucleus.

Journal of neurophysiology·2016

Same author

Heterogeneous calretinin expression in the avian cochlear nucleus angularis.

Journal of the Association for Research in Otolaryngology : JARO·2014

Same author

Heterogeneity of intrinsic biophysical properties among cochlear nucleus neurons improves the population coding of temporal information.

Journal of neurophysiology·2014

Same author

Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats.

British journal of pharmacology·2011

Same author

Novel Method of Digital Traction.

British medical journal·2010

Search research articles

Related Experiment Video

Updated: Jul 24, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Diabetes and driving: towards equitable, evidence-based decision-making.

¹Department of Diabetes and Vascular Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, UK.

Diabetic Medicine : a Journal of the British Diabetic Association

|April 29, 1999

Summary

New British driving restrictions for insulin-treated diabetes mellitus patients were introduced in 1998. A report examined accident risks, particularly from hypoglycemia, to address concerns from the diabetes community.

More Related Videos

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Related Experiment Videos

Last Updated: Jul 24, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Area of Science:

Diabetes Mellitus Management
Road Safety Regulations
Public Health Policy

Background:

In January 1998, the UK implemented new driving license restrictions for individuals with insulin-treated diabetes mellitus.
These regulations, based on the EU's second driver licensing directive (91/4389), threatened driving entitlements for light goods and small passenger vehicles.
Concerns were raised by the British diabetes community regarding these restrictions.

Purpose of the Study:

To examine and interpret existing evidence on accident risk associated with insulin-treated diabetes mellitus.
To specifically assess the risk of unexpected hypoglycemia in relation to driving safety.
To inform the British Diabetic Association's response to the new driving regulations.

Main Methods:

A comprehensive review of scientific literature and available data on accident risk in diabetic drivers.
Analysis focused on incidents linked to insulin therapy and hypoglycemic events.
Interpretation of evidence to understand the actual accident risk posed by insulin-treated diabetic drivers.

Main Results:

The article presents findings from a commissioned report that analyzed accident risks.
Evidence was interpreted to understand the specific risks, including those from hypoglycemia.
The report aimed to provide a data-driven perspective on the driving capabilities of insulin-treated diabetic individuals.

Conclusions:

The study provides an evidence-based interpretation of accident risks for insulin-treated diabetic drivers.
Findings are intended to inform discussions and policy regarding driving restrictions for this population.
The research addresses concerns within the diabetes community about maintaining driving privileges.